# FDA Inspection 1094217 - Delaware Institute for Reproductive Medicine, P.A - June 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/delaware-institute-for-reproductive-medicine-pa/637058bc-c8e1-4b70-9344-456c2eccbe8a
Source feed: FDA_Inspections

> FDA Inspection 1094217 for Delaware Institute for Reproductive Medicine, P.A on June 20, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094217
- Company Name: Delaware Institute for Reproductive Medicine, P.A
- Inspection Date: 2019-06-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1293390 - 2025-09-16](https://www.keypedia.com/records/fda_inspections/delaware-institute-for-reproductive-medicine-pa/acfe7588-74fd-4ac6-9d6c-1b0ac566c47b)
- [FDA Inspection 1293390 - 2025-09-16](https://www.keypedia.com/records/fda_inspections/delaware-institute-for-reproductive-medicine-pa/de7626c1-13ce-48bc-b19a-ed03bedd720c)
- [FDA Inspection 1187482 - 2022-10-26](https://www.keypedia.com/records/fda_inspections/delaware-institute-for-reproductive-medicine-pa/281a5796-9157-47c1-adad-96a432f96514)
- [FDA Inspection 1187482 - 2022-10-26](https://www.keypedia.com/records/fda_inspections/delaware-institute-for-reproductive-medicine-pa/0c985325-68f4-48e0-abdd-8537db9c450f)
- [FDA Inspection 1187482 - 2022-10-26](https://www.keypedia.com/records/fda_inspections/delaware-institute-for-reproductive-medicine-pa/6df89d39-dcd0-4949-89e9-6ac1019c4650)

Company: https://www.keypedia.com/companies/delaware-institute-for-reproductive-medicine-pa/15cecf6a-a321-4390-9048-921999542784

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d